SpacDeskBiotech & Pharma SPACs
5 active SPACs targeting Biotech & Pharma with $963.4M in trust.
The Biotech and Pharma sector currently hosts five active SPACs, four of which remain in active search mode while one has announced a definitive deal. Collectively, these vehicles have deployed approximately $963.4 million in capital, and their median days-to-expiration stands at 431 days, reflecting the extended diligence timelines that life-sciences transactions typically demand. Biotech-focused blank-check companies have long attracted specialized sponsors pursuing therapeutic pipelines, clinical-stage assets, and platform technologies across drug development and medical devices. To access full sponsor profiles, deal timelines, and real-time sector analytics across every active Biotech and Pharma SPAC, sign up for SpacDesk.
| SPAC | Sponsor | Trust | Status | IPO Date | Target | Deadline |
|---|---|---|---|---|---|---|
| DMIIU Drugs Made In America Acquisition II Corp. | Drugs Made In America Acquisition LLC | $575.0M | Searching | 2025-09-25 | — | 2027-09-25 |
| DMAAR Drugs Made In America Acquisition Corp. | Drugs Made In America Acquisition LLC | $231.2M | Deal Announced | 2025-01-29 | Power Analytics Global Corp | 2026-04-29 |
| TKBD TechyBird Acquisition Corp. | TechyBird LLC | $60.3M | Searching | — | — | — |
| BCGF BCGF Acquisition Corp. | BCGH, LLC | $58.4M | Searching | — | — | — |
| CGRD GRD Biotechnology Acquisition Ltd | — | $38.6M | Searching | — | — | — |
Active = status not liquidated/closed/withdrawn. Trust size reflects declared trust at IPO. Industry classification based on sponsor focus area and target company sector.